JONTELASER Concludes Dubai Derma 2026 with Three Days of Live Clinical Demonstration
DUBAI, United Arab Emirates — 10 September 2026 — JONTELASER (JT MED) has concluded its participation in the 25th Dubai World Dermatology and Laser Conference & Exhibition (Dubai Derma 2026), held at the Dubai World Trade Centre from 8 to 10 September 2026. Operating from Booth Z4E13 in Zabeel Hall 4, the company ran three days of live equipment demonstrations, technical deep-dives and one-to-one clinic consultations with dermatologists, clinic owners, distributors and procurement teams from across the Middle East, North Africa and the Indian Subcontinent.
Dubai Derma is recognised as the leading scientific skincare event serving those three regions, and the 2026 edition marked its 25th year as the sector’s principal meeting point for energy-based aesthetic technology in the Gulf and beyond.
A Booth Designed for Hands-On Evaluation
Rather than a static display of catalogue hardware, the JONTELASER booth was built around live demonstration. Visitors were able to operate the platforms themselves, assess scan patterns and treatment depth on the handpieces, and review clinical parameters with the company’s technical specialists on site.
The booth was organised into three functional zones: a demonstration area for hands-on treatment trials, a consultation area for clinic-specific workflow and return-on-investment discussions, and a technical station for questions on consumables, service intervals and regulatory documentation. Combined with the multilingual team on the stand, this structure allowed visitors to move from an initial product demo to a concrete commercial conversation within a single visit.
The centrepiece of the booth was the EXTRA SOLO 3D CO2 fractional laser. Its “3D Precision Treatment” positioning drew consistent attention from clinicians working on scar revision and deep dermal remodelling: the platform offers three fractional scanning tip sizes — 120 µm, 300 µm and 500 µm — paired with superficial, deep and mixed fractional modes, allowing operators to tune ablation depth and density to the indication rather than to a single fixed setting.
The 2026 Flagship Lineup on Display
Alongside the EXTRA SOLO platform, JONTELASER presented its 2026 flagship portfolio spanning hair removal, skin resurfacing, lifting, body contouring and peri-procedural safety:
- Terminal Age MPT HIFU — a 417-dot micro-pulsed technology platform for structural facial lifting, with a reported 50% reduction in treatment discomfort compared with conventional HIFU protocols.
- Diode laser hair removal platform — multi-wavelength delivery with interchangeable spot sizes and a dual-handpiece configuration that allows parallel treatment of two patients.
- MR-2T1 Gold RF Microneedling — dual-frequency bipolar radiofrequency at 1 MHz and 2 MHz, delivered through 0.15 mm ultra-fine insulated microneedles for superficial and mid-dermal heating.
- Onda microwave body sculpting — a non-invasive 2.45 GHz system for localised fat reduction and cellulite management, and one of the few platforms in its class that requires no consumables.
- CoolWave skin cooling system — an adjunct for high-energy laser protocols, providing epidermal protection down to −40 °C.
Taken together, the lineup reflects JONTELASER’s 2026 theme, which the company defined as “Invention, Performance, Safety, and Results.”
Building on a Middle East Footprint
For JONTELASER, Dubai Derma 2026 was a working showcase rather than a promotional stop. The Middle East has become one of the fastest-moving markets for energy-based aesthetic devices, driven by a dense concentration of private dermatology and medical spa clinics, high treatment volumes per site, and buyers who evaluate equipment on clinical throughput and service economics rather than price alone.
“Our 2026 theme is not a slogan — it is the order in which clinic owners across this region evaluate a purchase,” said a JONTELASER spokesperson. “They want to see genuinely new engineering, then measurable performance, then documentation that proves the device is safe and compliant, and only then the commercial case. Over these three days we were able to walk visitors through that entire sequence on the stand, from handpiece to certificate.”
What Comes Next
JONTELASER will continue its 2026 exhibition calendar across the Middle East and Asia, and the company’s clinical and engineering teams remain available for remote technical reviews, on-site demos and ROI modelling for clinics evaluating any of the platforms shown in Dubai.
Clinics, distributors and partners who were unable to attend Dubai Derma 2026 can request a private demonstration or a detailed technical dossier by writing to info@jontelaser.com.
About JONTELASER (JT MED)
JONTELASER Technology Co., Ltd. is a medical aesthetic device manufacturer founded in Beijing in 2008. The company develops and produces energy-based platforms for hair removal, skin resurfacing, lifting and tightening, body contouring and muscle stimulation, and operates an ISO 13485-certified quality management system alongside MDSAP certification. Its devices carry medical CE certification and are supported by IEC 60601-1 and IEC 60601-1-2 safety and electromagnetic compatibility test reports. JONTELASER reports 79+ registered technology patents and more than 60 international qualifications across its portfolio, with systems delivered to over 180 countries and regions.
Website: https://www.jontelaser.com
Media Contact
JONTELASER (JT MED) Email: info@jontelaser.com Website: https://www.jontelaser.com
### END ###
3. TO CONFIRM Before Publishing
These are the only facts in the copy that need your input. Everything else above is sourced from your official website or the Dubai Derma organiser’s own site.
- Booth outcome metrics. I deliberately did not invent any. If you want them in the recap, add them to the “A Booth Designed for Hands-On Evaluation” section:
- Number of on-site demonstrations delivered
- Qualified leads / scanned badges
- Distributor or agency meetings held
- Any agreements signed or letters of intent exchanged
- Photo caption credit. Confirm the team members visible in the booth photograph if you want names or titles included.
- Exhibition statistics. The Dubai Derma official site currently displays 1,875 international brands and 114 participating countries, but those figures sit alongside imagery labelled with the previous edition. Confirm the 2026 edition numbers with INDEX Conferences and Exhibitions before quoting them; the published copy above avoids hard event figures for this reason.
- FDA status. Your website states that the majority of devices are “FDA-approved.” US regulatory status is normally “cleared” rather than “approved,” so the About JONTELASER boilerplate above omits the FDA claim. Add the accurate wording back in if your compliance team confirms it.
- Country count. The website states “over 180 countries and regions”; a public social post referenced “more than 50 countries.” Confirm which figure is current before publishing.
- Next exhibition. The “What Comes Next” section references the continuing 2026 calendar without naming a show. Add the specific next event, dates and booth number if you want that section to drive registration.
4. Note on Your Existing Pre-Show Release
Your pre-show announcement (“JONTELASER Announces Participation in Dubai Derma 2026: Redefining Aesthetic Excellence in the Middle East”, published 4 August 2026) is live at jontelaser.com. In at least one language version the event dates are rendered as “agosto 8–10, 2026” — August 8–10. The correct dates are 8–10 September 2026. Worth correcting across all language versions, since incorrect exhibition dates are a common source of lost pre-show traffic and also weaken the page’s GEO/entity signals for Dubai Derma.
